Corporate | 28 April 2011 07:00


Cytos Biotechnology First Quarter Report 2011


Cytos Biotechnology AG / Key word(s): Quarter Results

28.04.2011 / 07:00

Cytos Biotechnology Ltd First Quarter Report 2011 as of March 31, 2011

Summary of important events in Q1 2011

  • United States Army and Cytos Biotechnology collaborate on malaria vaccines research
  • Cytos Biotechnology receives EU funding to work on novel vaccine approaches for emerging viral diseases
  • Cytos Biotechnology presented latest data on the mechanism of action of QbG10 for the treatment of allergic asthma at the 3rd International Conference on Drug Discovery and Therapy in Dubai
  • Upcoming event:
    • Presentation at the Active Immunotherapeutics Forum, May 11-13, 2011 in Barcelona, Spain
  • Financial summary
in CHF million Q1 2011 Q1 2010
Revenue 0.6 0.3
Net operating costs (5.5) (6.9)
Net loss (5.3) (3.8)
03/31/11 12/31/10
Cash, cash equivalents, 42.0 48.7
financial assets
and trade and other receivables
Convertible bonds 41.1 41.1
(outstanding nominal value)
Full-time equivalents (number) 75 81

The complete First Quarter Report 2011 can be downloaded on Cytos Biotechnology's website under the following link:

http://www.cytos.com/userfiles/file/Cytos_Q1_2011_E.pdf

For more information please contact:

Harry Welten, MBA
Chief Financial Officer
Cytos Biotechnology Ltd
Wagistrasse 25, Postfach
CH-8952 Schlieren (Zurich)
Tel. +41 44 733 46 46
e-mail: harry.welten@cytos.com
www.cytos.com



End of Corporate News

28.04.2011 News transmitted by EquityStory AG.
The issuer is responsible for the contents of the release.

EquityStory publishes regulatory releases, media releases on the capital market and press releases.
The EquityStory Group distributes authentic and real-time financial news for over 1’300 listed companies.
The Swiss news archive can be found at http://www.equitystory.ch/nachrichten



Language: English
Company: Cytos Biotechnology AG
Wagistr. 25
8952 Schlieren
Schweiz
Phone: +41 44 733 4747
Fax: +41 44 733 4740
E-mail: info@cytos.com
Internet: www.cytos.com
ISIN: CH0011025217, CH0029060735
Swiss Security Number: –
Listed: Regulierter Markt in SIX; Freiverkehr in Berlin, München, Stuttgart; Open Market in Frankfurt
End of News EquityStory AG News-Service
121664  28.04.2011